Traws Pharma, Inc. (TRAW) Total liabilities 2015–2024
Traws Pharma, Inc. (TRAW) total liabilities at each fiscal year-end, per SEC filings.
$11.2MFY2024 · since FY2015: $18.1M → $11.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $11.2M | -80.1% |
| FY2023 | $56.6M | +371.2% |
| FY2022 | $12.0M | +8.6% |
| FY2021 | $11.1M | +18.2% |
| FY2020 | $9.4M | -32.2% |
| FY2019 | $13.8M | +14.1% |
| FY2018 | $12.1M | -3.5% |
| FY2017 | $12.5M | -20.9% |
| FY2016 | $15.8M | -12.5% |
| FY2015 | $18.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Shareholders’ equityTRAW overview →